The FDA is alerting the health care and emergency response community that due to the ongoing critical shortages of injectable drugs used in critical care, Pfizer has provided updated dates through which some of these injectable drugs, manufactured by Hospira Inc., a Pfizer company, may be used beyond the manufacturer’s labeled expiration date. To help ensure patient safety, these products should have been — and should continue to be — stored as per labeled conditions. For specific information and the full FDA alert, go to https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm563360.htm